Avanos Medical, Inc. (AVNS)
 NYSE: AVNS · Real-Time Price · USD
 11.14
 -0.29 (-2.54%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Avanos Medical Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Avanos Medical in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Avanos Medical.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | 
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 | 
| Buy | 0 | 0 | 0 | 0 | 0 | 0 | 
| Hold | 2 | 2 | 2 | 2 | 2 | 0 | 
| Sell | 1 | 1 | 1 | 1 | 1 | 0 | 
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 | 
| Total | 4 | 4 | 4 | 4 | 4 | 0 | 
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date | 
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 7, 2024 | 
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 25, 2023 | 
| Stifel | Stifel | Hold Reiterates $25 | Hold | Reiterates | $25 | +124.42% | Jun 21, 2023 | 
| CL King | CL King | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +178.28% | May 22, 2023 | 
| Morgan Stanley | Morgan Stanley | Sell Maintains $28 → $26 | Sell | Maintains | $28 → $26 | +133.39% | May 4, 2023 | 
Financial Forecast
Revenue This Year
 689.52M 
 from 687.80M
 Increased by 0.25%
Revenue Next Year
 698.70M 
 from 689.52M
 Increased by 1.33%
EPS This Year
 0.81 
 from -8.53
EPS Next Year
 0.92 
 from 0.81
 Increased by 13.44%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 
|---|---|---|---|
| High | 709.8M | 719.3M | |
| Avg | 689.5M | 698.7M | |
| Low | 662.5M | 671.3M | 
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 
|---|---|---|---|
| High | 3.2% | 4.3% | |
| Avg | 0.3% | 1.3% | |
| Low | -3.7% | -2.6% | 
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 
|---|---|---|---|
| High | 0.84 | 0.95 | |
| Avg | 0.81 | 0.92 | |
| Low | 0.78 | 0.88 | 
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 
|---|---|---|---|
| High | - | 16.8% | |
| Avg | - | 13.4% | |
| Low | - | 9.0% | 
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.